NasdaqGS - Nasdaq Real Time Price USD

Bruker Corporation (BRKR)

Time to buy BRKR?

42.45

+1.69

+(4.15%)

As of 12:30:14 PM EDT. Market Open.

Time to buy BRKR?

Bruker First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Bruker ( NASDAQ:BRKR ) First Quarter 2025 Results Key Financial Results Revenue: US$801.4m (up 11% from 1Q 2024). Net...

Simply Wall St. 3 hours ago

BRKR
+4.15%
Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash

Bruker delivers better-than-expected earnings and revenues in the first quarter of 2025.

Zacks 4 hours ago

BRKR
+4.15%
Bruker Corp (BRKR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges

Bruker Corp (BRKR) reports an 11% revenue increase, driven by innovation and strategic actions, despite facing significant market headwinds.

GuruFocus.com 9 hours ago

BRKR
+4.15%
Q1 2025 Bruker Corp Earnings Call

Q1 2025 Bruker Corp Earnings Call

Thomson Reuters StreetEvents 11 hours ago

BRKR
+4.15%
Bruker Corporation (BRKR): A Bull Case Theory

We came across a bullish thesis on Bruker Corporation (BRKR) on Value Investing Subreddit Page by FckYouMoney. In this article, we will summarize the bulls’ thesis on BRKR. Bruker Corporation (BRKR)’s share was trading at $40.73 as of May 5th. BRKR’s trailing and forward P/E were 53.59 and 16.21 respectively according to Yahoo Finance. Bruker Corp., a […]

Insider Monkey 21 hours ago

BRKR
+4.15%
Compared to Estimates, Bruker (BRKR) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks yesterday

BRKR
+4.15%
Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 2.17% and 0.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks yesterday

BRKR
+4.15%
Bruker’s (NASDAQ:BRKR) Q1 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations

Scientific instrument company Bruker (NASDAQ:BRKR). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $801.4 million. The company’s full-year revenue guidance of $3.52 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.47 per share was 5.9% above analysts’ consensus estimates.

StockStory yesterday

BRKR
+4.15%
Bruker: Q1 Earnings Snapshot

BILLERICA, Mass. AP) — Bruker Corp. BRKR) on Wednesday reported first-quarter earnings of $17.4 million.

Associated Press Finance yesterday

BRKR
+4.15%
Bruker Reports First Quarter 2025 Financial Results

BILLERICA, Mass., May 07, 2025--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2025.

Business Wire yesterday

BRKR
+4.15%
Bruker (BRKR) Reports Q1: Everything You Need To Know Ahead Of Earnings

Scientific instrument company Bruker (NASDAQ:BRKR). will be reporting earnings tomorrow morning. Here’s what investors should know.

StockStory 2 days ago

BRKR
+4.15%
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 8 days ago

BRKR
+4.15%
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025

CHICAGO, April 25, 2025--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, including launch of CosMx WTX assay for subcellular spatial imaging of the whole transcriptome, the PaintScape™ platform for visualization of 3D genome architecture and chromosomal structure

Business Wire 13 days ago

BRKR
+4.15%
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis

EMERYVILLE, Calif., April 24, 2025--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis.

Business Wire 14 days ago

BRKR
+4.15%
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Question

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

StockStory 17 days ago

PENN

BRKR
+4.15%

BMI
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers.

StockStory 20 days ago

A

TECH

AVTR
Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns […]

Insider Monkey 20 days ago

BRKR
+4.15%

COMP
Bruker to invest in German company RECIPE

Both entities are working to launch chromatography-free RECIPE ClinDART kits.

Medical Device Network 21 days ago

BRKR
+4.15%
Bruker Introduces nVista 2P Miniature Microscope

SAN JOSE, Calif., April 17, 2025--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D data reconstruction, providing researchers with unprecedented insights into neuronal activity. Featuring several innovat

Business Wire 21 days ago

BRKR
+4.15%
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring

MUNICH, April 16, 2025--Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays.

Business Wire 22 days ago

BRKR
+4.15%

Performance Overview

Return	BRKR	S&P 500 (^GSPC)
YTD	-27.51%	-2.99%
1-Year	-42.20%	+9.99%
3-Year	-29.94%	+38.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bruker Corporation (BRKR)

Bruker First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash

Bruker Corp (BRKR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges

Q1 2025 Bruker Corp Earnings Call

Bruker Corporation (BRKR): A Bull Case Theory

Compared to Estimates, Bruker (BRKR) Q1 Earnings: A Look at Key Metrics

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker’s (NASDAQ:BRKR) Q1 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations

Bruker: Q1 Earnings Snapshot

Bruker Reports First Quarter 2025 Financial Results

Bruker (BRKR) Reports Q1: Everything You Need To Know Ahead Of Earnings

Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025

Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Question

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Bruker to invest in German company RECIPE

Bruker Introduces nVista 2P Miniature Microscope

Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring

Performance Overview